MAP Patient Access Limited

Based in the UK, and founded in 2012 by co-founders Christian Hill, and Dawn Hill, MAP Patient Access Limited is engaged in providing healthcare IT solutions and consultancy services that help patients in navigating pharmaceuticals, medicines, and diagnostics approaches across medical firms, biotechnology, and healthcare facilities. In March 2023, Kester Capital, a mid-market private equity firm acquired MAP Patient Access Limited. As of March 2023, the company has served over 450 clients and is led by its CEO Dan Spacie. MAP Patient Access Limited provides consultation on early engagement, evidence communication, legal support, health economics and outcome research, market access and marketing strategy, medtech early technical assessment tool, strategic planning, positioning and message development, political, economic, social, and technological analysis, policy and public affairs training, and media management.

Furthermore, the company provides market access tools such as international reference pricing (IRP) service, budget impact service using the budget impact model, market access planning tool, parliamentary event planning tool, revenue forecast model, and MAP membership. Following the acquisition in March 2023, the company plans to further accelerate its growth expansion and improve its pharmaceutical platform across the healthcare sector.